In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Joseph Dillon, MB, BCh, BAO
Advertisement
Articles by Joseph Dillon, MB, BCh, BAO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?
2
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
3
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
4
Lower EDIC May Improve Local Tumor Control in Lung Cancer
5
